CDEK
← All trials

NCT05708950

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Mar 3, 2023
Primary completion
Jun 30, 2024
Completion date
Dec 31, 2024
First posted
Feb 1, 2023
Last posted
Jul 13, 2023
Enrollment
314
Arms / groups
4 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.